These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 30408466

  • 21. RhoE Fine-Tunes Inflammatory Response in Myocardial Infarction.
    Dai Y, Song J, Li W, Yang T, Yue X, Lin X, Yang X, Luo W, Guo J, Wang X, Lai S, Andrade KC, Chang J.
    Circulation; 2019 Feb 26; 139(9):1185-1198. PubMed ID: 30586715
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.
    Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA.
    PLoS One; 2009 Feb 26; 4(3):e4973. PubMed ID: 19319192
    [Abstract] [Full Text] [Related]

  • 23. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
    Shiota C, Abe T, Kawai N, Ohno A, Teshima-Kondo S, Mori H, Terao J, Tanaka E, Nikawa T.
    J Nutr Sci Vitaminol (Tokyo); 2015 Feb 26; 61(2):188-94. PubMed ID: 26052151
    [Abstract] [Full Text] [Related]

  • 24. Loss of Protease-Activated Receptor 4 Prevents Inflammation Resolution and Predisposes the Heart to Cardiac Rupture After Myocardial Infarction.
    Kolpakov MA, Guo X, Rafiq K, Vlasenko L, Hooshdaran B, Seqqat R, Wang T, Fan X, Tilley DG, Kostyak JC, Kunapuli SP, Houser SR, Sabri A.
    Circulation; 2020 Aug 25; 142(8):758-775. PubMed ID: 32489148
    [Abstract] [Full Text] [Related]

  • 25. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes.
    Dehoux M, Van Beneden R, Pasko N, Lause P, Verniers J, Underwood L, Ketelslegers JM, Thissen JP.
    Endocrinology; 2004 Nov 25; 145(11):4806-12. PubMed ID: 15284206
    [Abstract] [Full Text] [Related]

  • 26. Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy.
    Castillero E, Akashi H, Wang C, Najjar M, Ji R, Kennel PJ, Sweeney HL, Schulze PC, George I.
    Biochem Biophys Res Commun; 2015 Jan 30; 457(1):106-11. PubMed ID: 25528587
    [Abstract] [Full Text] [Related]

  • 27. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass.
    Rom O, Reznick AZ.
    Free Radic Biol Med; 2016 Sep 30; 98():218-230. PubMed ID: 26738803
    [Abstract] [Full Text] [Related]

  • 28. Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells.
    Li JJ, Zhang TP, Meng Y, Du J, Li HH.
    Cell Physiol Biochem; 2011 Sep 30; 27(5):463-70. PubMed ID: 21691063
    [Abstract] [Full Text] [Related]

  • 29. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
    Li HH, Kedar V, Zhang C, McDonough H, Arya R, Wang DZ, Patterson C.
    J Clin Invest; 2004 Oct 30; 114(8):1058-71. PubMed ID: 15489953
    [Abstract] [Full Text] [Related]

  • 30. Identification of MAFbx as a myogenin-engaged F-box protein in SCF ubiquitin ligase.
    Jogo M, Shiraishi S, Tamura TA.
    FEBS Lett; 2009 Sep 03; 583(17):2715-9. PubMed ID: 19631210
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.